Fig. 1.
Overall survival of 381 patients, divided into the CROSS (n = 208) and post-CROSS (n = 173) cohorts for patients with oesophageal or junctional cancer who underwent chemoradiotherapy according to CROSS followed by surgery (p = 0.90). cum survival percentages of cumulative overall survival, where 1.0 means 100% of the cohort, decreasing over time, 5-year OS 5-year overall survival, expressed in months, CROSS ChemoRadiotherapy for Esophageal cancer followed by Surgery Study, mo months